Bessemer Group
CHRS icon

Bessemer Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bessemer Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-526
Closed -$2K – 2161
2023
Q3 		$2K Buy
+526
New +$2K ﹤0.01% 1947